🎙️ Just published a new episode of Blood Podcast: Exploiting Vulnerabilities in High‑Risk MM and Mapping the Red Cell Interactome. Have a listen:

Exploiting Vulnerabilities in High‑Risk MM and Mapping the Red Cell Interactome

In this week's episode, Blood editor Dr. Laurie Sehn interviews Drs....

bloodpodcast.transistor.fm

🎙️ Just published a new episode of Blood Podcast: MYB driven ALL and Venetoclax-Azacitidine damage to Bone Marrow. Have a listen:

MYB driven ALL and Venetoclax-Azacitidine damage to Bone Marrow

In this week's episode, Blood editor Dr. James Griffin interviews Drs....

bloodpodcast.transistor.fm

Advances in the treatment of major blood cancers have saved more than 25 million years of life in the United States over the past 75 years. But gains have not reached everyone equally. Read more from Blood Cancer United new in Blood Journal https://ow.ly/H1iv50ZIgiH

New issue of Blood Global Hematology out now featuring Inequities in clinical trial availability in Europe, The correlation between Hb and the clinical spectrum of SCA, Rethinking Hispanic/Latino as an ethnic category in leukemia research and more. Explore here: ashpublications.org/bloodglobal/...

New issue of Blood out now featuring The hidden role of neutrophils in steroid-resistant GVHD, IL-16 drives a novel pathway of BTK inhibitor resistance, Precision transfusion medicine in the omics era and more. Explore here: ashpublications.org/blood/issue/...

🎙️ Just published a new episode of Blood Podcast: Predictive Markers of Glofitamab Resistance in R/R B-NHL. Have a listen:

Predictive Markers of Glofitamab Resistance in R/R B-NHL

In this week's episode, Blood editor Dr. Laurie Sehn interviews Drs....

bloodpodcast.transistor.fm

Proud to share our @ash.hematology.org @bloodjournals.hematology.org, led by my trainee Dr. @vpizzuti.bsky.social @cuinternalmed.bsky.social. Longitudinal PROs and QoL trajectories over 2 years after CAR T-cell therapy. #lymsm #mmsm🧵 doi.org/10.1016/j.bn...

New issue of Blood Neoplasia is out featuring Co-option of lineage plasticity as a hallmark of multipotent acute leukemias, Autologous transplant for patients with chemotherapy-sensitive late relapse of diffuse large B-cell lymphoma and more. Explore here: ashpublications.org/bloodneoplas...

New issue of Blood VTH out now! Featuring New insights into flavonoid binding to the thromboxane A2 receptor, Sirolimus outperforms alpelisib in models of NRASQ61R-driven vascular overgrowth, and more. Explore here: ashpublications.org/bloodvth/iss...

Writing in Blood Advances, Layla Van Doren, MD, and colleagues report increased #burnout among #physicians focused on #SickleCell disease (SCD) compared to their non-SCD-focused peers. medicine.yale.edu/publication-... @bloodjournals.hematology.org

🎙️ Just published a new episode of Blood Podcast: Better Together: Adding daratumumab for AL Amyloidosis and and Mezigdomide for MM. Have a listen:

Better Together: Adding daratumumab for AL Amyloidosis and and Mezigdomide for MM

In this week's episode, Blood editor Laurie Sehn interviews Drs....

bloodpodcast.transistor.fm

🎙️ Just published a new episode of Blood Podcast: Balancing Infection and Thrombosis: Bispecific Antibodies and the Many Roles of HRG. Have a listen:

Balancing Infection and Thrombosis: Bispecific Antibodies and the Many Roles of HRG

In this week's episode, Blood editor Dr. Laura Michaelis interviews Drs....

bloodpodcast.transistor.fm

Enjoyed this @bloodjournals.hematology.org editorial regarding the longterm follow-up of CALGB10403 in AYA patients with ALL ashpublications.org/bloodadvance...

Long-term lessons from CALGB 10403

In this issue of Blood Advances, Silva et al1 report on the 10-year follow-up data from CALGB 10403, the landmark US Intergroup trial that established a pe

ashpublications.org

New in Blood @bloodjournals.hematology.org lenalidomide (maintenance tx in myeloma) raises B-ALL risk. We show WHY in a subset of cases IDH2 R140Q clonal hematopoiesis + lenalidomide-driven IKAROS loss cooperate to arrest B-cell dev., seeding a distinct leukemia subtype. 🧵 doi.org/10.1182/bloo...

IDH2 clonal hematopoiesis and IKAROS loss cooperate in a B-ALL subtype after lenalidomide therapy for multiple myeloma

Key PointsIDH2 R140Q mutations define a distinct B-ALL subtype that is highly enriched in LenB-ALL.IDH2mt LenB-ALL emerges from IDH2-mutant clonal hematopo

doi.org

🎙️ Just published a new episode of Blood Podcast: Cost-Effectiveness of Current SCD Treatments and Potential Therapeutic Targets for Fetal Hemoglobinopathies. Have a listen:

Cost-Effectiveness of Current SCD Treatments and Potential Therapeutic Targets for Fetal Hemoglobinopathies

In this week's episode, Blood editor Dr. James Griffin interviews Drs....

bloodpodcast.transistor.fm

After more than 30 years of extraordinary leadership, Martha "Marty" Liggett, Esq., will retire as ASH Executive Director. The Society has named Matthew Gertzog, FASAE, MBA, as its next Chief Executive Officer, effective January 1, 2027. Learn more: https://ow.ly/XRag50ZxEhX #HemeSky

New issue of Blood out now featuring Discovery and preclinical activity of ziftomenib, Single-day nonactivated IL-18 CAR T-cell therapy, RAASi and anemia in SCD, and more. Explore here: ashpublications.org/blood/issue/...

Congratulations to my mentee Dr. @vpizzuti.bsky.social on this analysis of 2 years of PRO data in CAR-T recipients, now published @bloodjournals.hematology.org. CAR-T confers long-term QoL benefits, and worsening patient-reported fatigue at D+15 may predict subsequent response as a "PRO-marker."

🎙️ Just published a new episode of Blood Podcast: HLH-like toxicities after CAR-T and Structure-Function Relationships of FNAIT. Have a listen:

HLH-like toxicities after CAR-T and Structure-Function Relationships of FNAIT

In this week's episode, Blood editor Dr. Laura Michaelis interviews Drs....

bloodpodcast.transistor.fm

This Thursday, join the ASH Journal Club webinar to explore how integrated omics data, mouse models, and CRISPR screening are advancing research in NPM1-mutant AML. Enroll now: https://ow.ly/7RQS50ZtnWa #HemeSky

New issue of Blood out now featuring Epigenetic toggling between multipotency and differentiation, Nanotube trafficking fuels myeloma bone loss, Promises and potential pitfalls of in vivo CAR gene therapy, and more. Explore here: ashpublications.org/blood/issue/...

🎙️ Just published a new episode of Blood Podcast: FLT3-ITD microclones in AML and Results from the RESET-PV trial. Have a listen:

FLT3-ITD microclones in AML and Results from the RESET-PV trial

In this week's episode, Blood editor Dr. Laura Michaelis interviews Drs....

bloodpodcast.transistor.fm

New issue of Blood out now featuring ASH HematOmics Program, Clinical spectrum of hereditary hemorrhagic telangiectasia, RNF217 modulates iron metabolism, and more. Explore here: ashpublications.org/blood/issue/...

🎙️ Just published a new episode of Blood Podcast: Initial CHORUS data on HHT and ASH HematOmics Program. Have a listen:

Initial CHORUS data on HHT and ASH HematOmics Program

In this week's episode, Blood editor Dr. James Griffin interviews Drs....

bloodpodcast.transistor.fm

New issue of Blood out now featuring OutFOXing a FENDRR bender in T-ALL, Crossing the trial-practice chasm in CAR-T for relapsed LBCL, Oxidized PDI promotes thrombus formation, and more. Explore here: ashpublications.org/blood/issue/...

🎙️ Just published a new episode of Blood Podcast: IV Iron during Acute Infection and Revisiting iTTP Refractoriness . Have a listen:

IV Iron during Acute Infection and Revisiting iTTP Refractoriness

In this week's episode, Blood editor Dr. James Griffin interviews Drs....

share.transistor.fm

New issue of Blood out now featuring MDM4-related bone marrow failure, Pavurutamab in relapsed myeloma, Phenotype-driven analysis of PIEZO1 variants, and more. Explore here: ashpublications.org/blood/issue/...

🎙️ Just published a new episode of Blood Podcast: A Pediatric ITP Risk Model and Targeting CD2 with CAR T-cell therapies . Have a listen:

A Pediatric ITP Risk Model and Targeting CD2 with CAR T-cell therapies

In this week's episode, Blood editor Dr. Laura Michaelis interviews Drs....

share.transistor.fm

🎙️ Just published a new episode of Blood Podcast: IV Iron Risks and Low-Dose AML Gains. Have a listen:

IV Iron Risks and Low-Dose AML Gains

In this week's episode, Blood editor Dr. James Griffin interviews Drs....

share.transistor.fm

We're thrilled to welcome a new Associate Editor to Blood today! Dr. Omar Abdel-Wahab is the Evnin Family Chair of Molecular Pharmacology at @mskcancercenter.bsky.social where he also serves as Chair of the Molecular Pharmacology Program in the Sloan Kettering Institute. #NewEditor